Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysosome stabilization refers to the cellular processes and molecular mechanisms that maintain the integrity of lysosomal membranes, preventing their rupture and uncontrolled release of hydrolytic enzymes into the cytoplasm. This is crucial for cell survival, as lysosomal membrane permeabilization can trigger cell death pathways and contribute to various diseases. Key mechanisms include glycocalyx protection by LAMP1/LAMP2, ESCRT-mediated resealing, ATG8 lipidation, transcriptional response via TFEB/TFE3, and the LYTL pathway involving LRRK2/RABs. Impaired stabilization can lead to neurodegeneration and cancer progression, while enhanced stability may treat degenerative diseases and increase tissue regeneration.
Enhancing membrane integrity or modulating key regulators like TFEB/LRRK2/RABs/LAMPs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosome Stabilization.